A new pill was recently tested for obstructive sleep apnea, a disease that causes loud snoring. The results suggest a simpler ...

Please provide your email address to receive an email when new articles are posted on . Those with vs. without severe obstructive sleep apnea faced an 87% greater risk for being hospitalized with ...

In a recent study published in the New England Journal of Medicine, researchers investigated the effects of tirzepatide on adults with obesity and moderate-to-severe obstructive sleep apnea (OSA).

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

A part of the brain connected to memory shrank in people with severe sleep-disordered breathing — which can include heavy snoring and sleep apnea — according to a new study. People with sleep apnea ...

Sleep apnea is prevalent in patients with HF, adding a high-risk comorbidity that can persist even after heart transplant, say the authors of a new study. The findings highlight the important role ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Uncontrolled sleep apnea — a disorder in which people stop breathing for 10 seconds or more at a time multiple times a night — may harm future brain health, a new study found. It’s estimated 936 ...

A new sleep apnea pill reduced symptoms by 44 per cent in trials, offering hope for patients struggling with uncomfortable ...

Share on Pinterest Could obstructive sleep apnea affect a person’s cognitive function? Image credit: Enes Evren/Getty Images. Obstructive sleep apnea is the most common type of sleep-breathing ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...